14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $260.68 $288.54 Wednesday, 24th Apr 2024 AMGN stock ended at $273.01. This is 0.194% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 1.93% from a day low at $269.65 to a day high of $274.86.
90 days $260.68 $329.72
52 weeks $211.73 $329.72

Historical Amgen Inc. prices

Date Open High Low Close Volume
Jul 13, 2021 $245.39 $246.75 $242.98 $244.83 1 604 373
Jul 12, 2021 $244.49 $247.90 $243.54 $244.37 2 124 837
Jul 09, 2021 $243.09 $245.93 $241.71 $245.20 1 600 958
Jul 08, 2021 $244.24 $246.70 $242.45 $244.28 1 969 341
Jul 07, 2021 $244.07 $244.28 $241.34 $243.22 2 357 419
Jul 06, 2021 $247.26 $248.12 $243.17 $243.65 2 752 732
Jul 02, 2021 $247.33 $249.90 $246.25 $248.70 1 897 481
Jul 01, 2021 $243.74 $247.10 $243.55 $246.90 2 063 388
Jun 30, 2021 $242.72 $244.27 $242.06 $243.75 2 318 571
Jun 29, 2021 $243.22 $243.94 $242.06 $242.46 1 337 116
Jun 28, 2021 $244.03 $245.51 $242.66 $242.84 1 679 910
Jun 25, 2021 $241.64 $243.65 $240.11 $242.68 3 949 721
Jun 24, 2021 $240.41 $243.03 $239.29 $240.95 1 929 273
Jun 23, 2021 $239.65 $239.75 $236.93 $238.71 1 603 361
Jun 22, 2021 $239.71 $240.75 $238.29 $239.91 1 775 061
Jun 21, 2021 $239.64 $240.91 $237.65 $240.24 2 096 628
Jun 18, 2021 $239.58 $241.00 $236.47 $238.68 5 550 440
Jun 17, 2021 $239.54 $242.43 $238.34 $240.76 2 138 489
Jun 16, 2021 $240.87 $244.51 $238.00 $239.58 3 145 814
Jun 15, 2021 $241.74 $241.98 $239.05 $239.85 2 505 146
Jun 14, 2021 $242.56 $242.72 $239.29 $241.19 2 082 807
Jun 11, 2021 $244.88 $245.50 $241.98 $242.77 2 001 716
Jun 10, 2021 $239.57 $245.33 $239.22 $244.64 2 621 975
Jun 09, 2021 $237.92 $241.31 $236.73 $239.52 3 026 252
Jun 08, 2021 $238.93 $239.12 $235.25 $236.82 1 637 831
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT